GUER
Guerrilla RF, Inc.
$3.00
+0.50%
No data for this timeframe.
Vol
Insider Activity2B / 0S
Insider Net $$15.6K
SEC Reports5
Recent Activity
May 19, 2026
SEC
Two insiders (CFO Michael John-Williams and Director James Dunn) made modest open-market purchases totaling $16K on May
CLUSTER — Impact 3/10
May 19, 2026
SEC
GUER insiders bought $16K in open-market stock plus seven executives/directors received restricted stock grants (non-cas
CLUSTER — Impact 4/10
May 19, 2026
SEC
Two insiders (Director and CFO) made small open-market purchases totaling ~$16K following a strong Q1 2026 earnings repo
CLUSTER — Impact 3/10
May 15, 2026
Insider
John-Williams Michael was granted 32,500 shares
Chief Financial Officer
May 15, 2026
Insider
Mason Mark Alan was granted 27,500 shares
Chief Operating Officer
May 15, 2026
Insider
Chong Kellie Hyon-Ok was granted 20,000 shares
Chief Business Officer
Latest Reports
NEUTRAL
CLUSTER
3/10
Two insiders (CFO Michael John-Williams and Director James Dunn) made modest open-market purchases totaling $16K on May
May 19, 2026
NEUTRAL
CLUSTER
4/10
GUER insiders bought $16K in open-market stock plus seven executives/directors received restricted stock grants (non-cas
May 19, 2026
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 15, 2026 | John-Williams Michael | A | $0.00 |
| May 15, 2026 | Mason Mark | A | $0.00 |
| May 15, 2026 | Chong Kellie | A | $0.00 |
| May 15, 2026 | Dunn James | A | $0.00 |
| May 15, 2026 | Pratt Ryan | A | $0.00 |
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
12 unique insiders with 16 transactions. Net insider value: $15.6K ($15.6K bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 15, 2026 | John-Williams Michael | Chief Financial Officer | AWARD | 32,500 | — | — |
| May 15, 2026 | Mason Mark Alan | Chief Operating Officer | AWARD | 27,500 | — | — |
| May 15, 2026 | Chong Kellie Hyon-Ok | Chief Business Officer | AWARD | 20,000 | — | — |
| May 15, 2026 | Dunn James E. Jr. | Director | AWARD | 15,625 | — | — |
| May 15, 2026 | Pratt Ryan Michael | Chief Executive Officer | AWARD | 45,000 | — | — |
| May 15, 2026 | PRATT WILLIAM J | Director | AWARD | 15,625 | — | — |
| May 15, 2026 | SMITH GARY L /NC/ | Director | AWARD | 15,625 | — | — |
| May 15, 2026 | SUMMERELL VIRGINIA R | Director | AWARD | 15,625 | — | — |
| May 15, 2026 | Barkal Susan Berish | Director | AWARD | 15,625 | — | — |
| May 15, 2026 | HAMMER TODD B | Director | AWARD | 15,625 | — | — |
| May 15, 2026 | ELLIS THOMAS B | Director | AWARD | 15,625 | — | — |
| May 15, 2026 | BELL DAVID B | Director | AWARD | 15,625 | — | — |
| May 13, 2026 | John-Williams Michael | Chief Financial Officer | BUY | 2,000 | $2.82 | $5.6K |
| May 13, 2026 | Dunn James E. Jr. | Director | BUY | 3,335 | $3.00 | $10.0K |
| Nov 17, 2025 | John-Williams Michael | Chief Financial Officer | AWARD | 46,534 | — | — |
| Nov 17, 2025 | John-Williams Michael | Chief Financial Officer | AWARD | 46,534 | — | — |
5 SEC filing reports analyzed. Sentiment: 1 bullish, 1 bearish, 0 mixed, 3 neutral. Avg impact: 4.6/10.
NEUTRAL
CLUSTER
3/10
Two insiders (CFO Michael John-Williams and Director James Dunn) made modest open-market purchases t
May 19, 2026
NEUTRAL
CLUSTER
4/10
GUER insiders bought $16K in open-market stock plus seven executives/directors received restricted s
May 19, 2026
NEUTRAL
CLUSTER
3/10
Two insiders (Director and CFO) made small open-market purchases totaling ~$16K following a strong Q
May 19, 2026
BEARISH
EFFECT
6/10
Guerrilla RF, Inc. received SEC effectiveness on May 6, 2026 for four separate registration statemen
May 7, 2026
BULLISH
8-K
7/10
Guerrilla RF reported Q1 2026 revenue of $6.5M (+48% YoY), gross margin expansion to 69.9% (+880 bps
May 6, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2024-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.